Supplementation of Cheonggukjang and red ginseng Cheonggukjang can improve plasma lipid profile and fasting blood glucose concentration in subjects with impaired fasting glucose

Journal of Medicinal Food

Volumn 14, Issue 1-2, 2011, Pages 108-113

  Shin, Su Kyung ^a   Kwon, Joong Ho ^a   Jeong, Yong Jin ^b   Jeon, Seon Min ^a   Choi, Seon Min ^a   Choi, Myung Sook ^a  

^a Kyungpook National University   (South Korea)

^b Keimyung University   (South Korea)

Author keywords

fermented foods; human; lipids

Indexed keywords

ANTIDIABETIC AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CARBOHYDRATE; CHEONGGUKJANG EXTRACT; CHOLESTEROL; GINSENG EXTRACT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PROTEIN; RED GINSENG CHEONGGUKJANG EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; DIETARY FIBER; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; ERYTHROCYTE LEVEL; FASTING BLOOD GLUCOSE; FEMALE; GINSENG; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; SOYBEAN; TREATMENT DURATION;

ADULT; BACILLUS SUBTILIS; BLOOD GLUCOSE; FEMALE; FERMENTATION; HUMANS; LIPIDS; MALE; MIDDLE AGED; PANAX; PLANT EXTRACTS; PREDIABETIC STATE; SOY FOODS; SOYBEAN PROTEINS;

PANAX GINSENG;

EID: 79952093907     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2009.1366     Document Type: Article

References (36)

1. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-3167.
2. International Diabetes Federation: Impaired Glucose Tolerance (IGT). 2003. www.idf.org/fact-sheet-impaired-glucose-tolerance-igt (accessed October 2009).
3. Kim HY, Okamoto T, Yokozawa T: Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advanced glycation endproducts, and oxidative stress in streptozotocin-induced diabetic rats. J Ethnopharmacol 2009;124:263-269.
4. Jenkins DJ, Kendall CW, Marchie A, Jenkins AL, Augustin LS, Ludwig DS, Barnard ND, Anderson JW: Type 2 diabetes and the vegetarian diet. Am J Clin Nutr 2003;78(3 Suppl):610S-616S.
5. Nakakima N, Nozoki N, Ishihara K, Ishikawa A, Tsuji H: Analysis of isoflavone content in tempeh, a fermented soybean, and preparation of a new isoflavone-enriched tempeh. J Biosci Bioeng 2005;100:685-687. (Pubitemid 44354361)
6. rd, Kim HJ, Park S: Antidiabetic effects of fermented soybean products on type 2 diabetes. Nutr Res 2010;30:1-13.
7. Huang KC, Walter MW: The Pharmacology of Chinese Herbs. CRC Press, Boca Raton, FL, 1999.
8. Yoon S-R, Lee G-D, Park J-H, Lee I-S, Kwon J-H: Ginsenoside composition and antiproliferative activities of explosively puffed ginseng (Panax ginseng C.A. Meyer). J Food Sci 2010;75:C378-C382.
9. International Ethical Guideline for Biomedical Research Involving Human Subjects: Prepared by the Council for International Organizations of Medical Sciences (CIOMS) in collaboration with the World Health Organization (WHO). Council for International Organizations of Medical Sciences, Geneva, 2002.
10. Park NY, Seong JH, Choi MS, Moon KD, Kwon JH, Jeong YJ: Comparison of functional properties of cheonggukjang by using red ginseng. J Korean Soc Food Sci Nutr 2008;37:261-268.
11. Jeong YJ, Woo SM, Kwon JH, Choi MS, Seong JH, Lee JW: Quality characteristics of red ginseng cheonggukjang according to addition methods of red ginseng. J Korean Soc Food Sci Nutr 2007;36:889-895.
12. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of LDL-cholesterol in plasma, without use of the ultracentrifuge. Clin Clem 1972;18:499-502.
13. Tarladgis BG, Pearson AM, Dugan LR: Chemistry of the 2- thiobarbituric acid test for determination of oxidative rancidity in foods. J Sci Food Agric 1964;15:602-607.
14. Witschi JC: Short-term dietary recall and recording methods. In: Nutritional Epidemiology (Willett W, ed.). Oxford University Press, New York, 1998, pp. 52-68.
15. Omoni AO, Aluko RE: Soybean foods and their benefits; potential mechanisms of action. Nutr Rev 2005;63:272-283. (Pubitemid 41176916)
16. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2009;32(Suppl 1):S62-S67.
17. van der Steeg WA, Boekholdt SM, Stein EA, El-Harchaoui K, Stroes ES, Sandhu MS, Wareham NJ, Jukema JW, Luben R, Zwinderman AH, Kastelein JJ, Khaw KT: Role of the apolipoprotein B-apolipoprotein A-1 ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk. Ann Intern Med 2007;146:640-648. (Pubitemid 351650519)
18. American Heart Association: Cholesterol Levels - The Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. www .americanheart.org/presenter.jhtml?identifier=4500 (accessed October 2009).
19. Yamamoto Y, Takahashi Y, Kawano M, Iizuka M, Matsumoto T, Saeki S, Yamaguchi H: In vitro digestibility and fermentability of levan and its hypocholesterolemic effects in rats. J Nutr Biochem 1999;10:13-18.
20. Yokota T, Hattori T, Ohishi H, Hasegawa K, Watanabe K: The effect of antioxidant-containing fraction from fermented soybean food on atherosclerosis development in cholesterol-fed rabbits. Food Sci Technol LWT 1996;29:751-755. (Pubitemid 126162601)
21. American Heart Association. 2008. www.heart.org/ HEARTORG/Conditions/ Cholesterol/AboutCholesterol/Goodvs- Bad-Cholesterol-UCM-305561-Article.jsp (accessed October 2009).
22. Pyo Y-H, Seong K-S: Hypolipidemic effects of Monascus-fermented soybean extracts in rats fed a high-fat and -cholesterol diet. J Agric Food Chem 2009;57:8617-8622.
23. Sacks FM: The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations. Am J Cardiol 2002;90:139-143.
24. Rafael C, Patrick D, Fruchart J-C: Atherogenic lipoprotein particles in atherosclerosis. Circulation 2004;109(Suppl III):III-2-III-7.
25. Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL: Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001;161:1413-1419. (Pubitemid 32681162)
26. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
27. Nakamura Y, Yabe K, Shimada K, Sasaki K, Han KH, Okada T, Sekikawa M, Ohba K, Ito N, Horiuchi K, Kawakami S, Fukushima M: Effect of fermented bean paste on serum lipids in rats fed a cholesterol-free diet. Biosci Biotechnol Biochem 2009;73:2506-2512.
28. Jovin IS, Muller-Berghaus G: Inter-relationships between the fibrinolytic system and lipoproteins in the pathogenesis of coronary atherosclerosis. Atherosclerosis 2004;174:225-233. (Pubitemid 38597079)
29. Takami S, Yamashita S, Kihara S, Ishigami M, Takemura K, Kume N, Kita T, Matsuzawa Y: Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells. Circulation 1998;97:721-728. (Pubitemid 28135333)
30. Corsetti J, Zareba W, Moss A, Sparks C: Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndrome. Atherosclerosis 2004;177:367-373. (Pubitemid 39505270)
31. Pipe EA, Gobert CP, Capes SE, Darlington GA, Lampe JW, Duncan AM: Soy protein reduces serum LDL cholesterol and the LDL cholesterol:HDL cholesterol and apolipoprotein B:apolipoprotein A-1 ratios in adults with type 2 diabetes. J Nutr 2009;139:1700-1706.
32. Altavilla D, Saitta A, Cucinotta D, Galeano M, Deodato B, Colonna M, Torre V, Russo G, Sardella A, Urna G, Campo GM, Cavallari V, Squadrito G, Squadrito F: Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. Diabetes 2001;50:667-674. (Pubitemid 32195234)
33. Lai M-H: Antioxidant effects and insulin resistance improvement of chromium combined with vitamin C and E supplementation for type 2 diabetes mellitus. J Clin Biochem Nutr 2008;43:191-198.
34. Gallou G, Ruelland A, Legras B, Maugendre D, Allannic H, Cloarec L: Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clin Chim Acta 1993;214:227-234. (Pubitemid 23102293)
35. Fujita H, Yamagami T: Fermented soybean-derived Touchiextract with anti-diabetic effect via alpha-glucosidase inhibitory action in a long-term administration study with KKAy mice. Life Sci 2001;70:219-227. (Pubitemid 33153124)
36. Kim DJ, Jeong YJ, Kwon JH, Moon KD, Kim HJ, Jeon SM, Lee MK, Park YB, Choi MS: Beneficial effect of chungkukjang on regulating blood glucose and pancreatic beta-cell function in C57BL/KsJ-db/db mice. J Med Food 2008;11:215-223. (Pubitemid 351948172)